Details for: CL0002496

Cell ID: CL0002496

Cell Name: intraepithelial lymphocyte

Description: A tissue-resident lymphocyte located within the epithelial layer of mucosal tissues, particularly within the gastrointestinal, respiratory, and reproductive tracts. Characterised by permanent residency, this cell typically expresses CD103 (integrin alpha-E), which binds to E-cadherin on epithelial cells, enabling epithelial retention in both mice and humans. Phenotypically, IEL displays an activated, antigen-experienced state characterised by the constitutive expression of cytotoxic molecules (granzyme B, perforin) and innate-like receptors (such as NKG2D), enabling rapid, localised surveillance and immediate response to epithelial stress.

Synonyms: IEL, intraepithelial T cell, intraepithelial T-cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for intraepithelial lymphocyte within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for intraepithelial lymphocyte. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for intraepithelial lymphocyte. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for intraepithelial lymphocyte. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  intraepithelial lymphocyte (CL0002496)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [intraepithelial lymphocyte](/details-cell/CL0002496) (IEL) is a tissue-resident lymphocyte that functions as a sentinel cell within mucosal epithelial layers. The provided gene significance data strongly suggest that a defining characteristic of this cell type is an exceptionally high and specific metabolic activity. **Overall**, the top marker genes are dominated by components of the mitochondrial electron transport chain, including [COX1](/details-gene/4512), [COX2](/details-gene/4513), and [ND4](/details-gene/4538). This unique metabolic signature likely fuels the IEL's described state of constant surveillance and readiness for rapid cytotoxic response to epithelial stress or infection. ## Key Characteristics and Function Analysis of the top marker genes, ranked by expression specificity (`csi_z`), reveals several core functional clusters that define the [intraepithelial lymphocyte](/details-cell/CL0002496). * **Exceptional Mitochondrial Metabolism:** The most prominent feature of the IEL gene signature is the highly specific expression of numerous mitochondrial genes essential for oxidative phosphorylation. Genes encoding subunits of cytochrome c oxidase ([COX1](/details-gene/4512), [COX2](/details-gene/4513)), NADH dehydrogenase ([ND4](/details-gene/4538), [ND3](/details-gene/4537), [ND1](/details-gene/4535)), ATP synthase ([ATP6](/details-gene/4508), [ATP5F1E](/details-gene/514)), and cytochrome b ([CYTB](/details-gene/4519)) are among the most specific markers. This indicates that IELs are defined by a state of high metabolic readiness, distinguishing them from other cell types and likely underpinning their capacity for immediate effector functions without the need for extensive metabolic reprogramming. * **Cytotoxic Lymphocyte Identity:** The cell's identity as a T lymphocyte is confirmed by the high specificity of [CD7](/details-gene/924). Its role in immunity and cytotoxicity is further established by markers such as Beta-2-microglobulin ([B2M](/details-gene/567)) and the non-classical MHC molecule [HLA E](/details-gene/3133), which are critical for antigen presentation and interactions with other immune cells. The high significance of [GZMA](/details-gene/3001), a serine protease stored in cytotoxic granules, directly supports the cell's description as possessing a pre-armed, cytotoxic phenotype. Additionally, [FCER1G](/details-gene/2207), a common gamma chain for various Fc receptors, suggests a capacity to respond to antibody-mediated signals. * **Stress Response and Tissue Surveillance:** The high specificity of genes associated with cellular stress and damage response highlights the IEL's function in a challenging microenvironment. [HMGB1](/details-gene/3146), a key damage-associated molecular pattern (DAMP) molecule, suggests IELs may play a role in signaling tissue distress to the broader immune system. Furthermore, high expression of genes involved in iron homeostasis ([FTH1](/details-gene/2495), [FTL](/details-gene/2512)) and detoxification ([GSTP1](/details-gene/2950)) is consistent with a cell adapted to survive and function in an environment with high oxidative stress and potential exposure to xenobiotics. * **Anti-Markers:** The lack of specificity for genes such as the Fas ligand ([FASLG](/details-gene/356)) and the C-type lectin [KLRB1](/details-gene/3820) may indicate that while IELs are potent cytotoxic cells, they may rely on specific pathways (e.g., granzyme/perforin) over others (e.g., Fas-FasL) for their effector function. The low specificity for key cell cycle regulators like [E2F4](/details-gene/1874) is consistent with a terminally differentiated, non-proliferative resident population. ## Clinical Significance and Contextual Roles Given their location and pre-activated state, IELs are critical players in mucosal health and disease. Their functions are deeply implicated in inflammatory bowel disease (IBD), celiac disease, and colorectal cancer. The profound metabolic signature observed here has significant clinical implications. The heavy reliance on oxidative phosphorylation could render IELs uniquely vulnerable to hypoxic conditions or metabolic inhibitors, which may occur during severe inflammation or within a tumor microenvironment. This metabolic profile could be a target for therapeutic intervention, potentially to either suppress IEL activity in autoimmune conditions or enhance it for anti-tumor responses. The expression of [GZMA](/details-gene/3001) and [HMGB1](/details-gene/3146) positions IELs as central figures in the balance between protective immunity and immunopathology. While their cytotoxic activity is crucial for clearing infected or transformed epithelial cells, dysregulated activity can lead to epithelial barrier destruction, as seen in IBD. The release of [HMGB1](/details-gene/3146) can further amplify inflammation by recruiting and activating other immune cells. Understanding the regulation of these dual functions is key to harnessing their therapeutic potential. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The uniquely high and specific expression of mitochondrial oxidative phosphorylation machinery is not merely a marker of an activated state but is a central, hard-wired feature that dictates the IEL's sentinel function. This metabolic pre-configuration allows IELs to maintain a state of "metabolic readiness," enabling them to execute immediate effector functions without the temporal delay associated with the glycolytic switch seen in naive lymphocytes upon activation. * **Surprising Findings:** The most specific genetic markers for this immune cell are not surface receptors or cytokines, but core components of mitochondrial respiration. This challenges the conventional surface-marker-centric view of lymphocyte identification and suggests that metabolic phenotype can be a primary defining characteristic. * **Testable Questions:** How does the basal rate of oxygen consumption in IELs compare to that of circulating naive and effector T cells? Does targeted pharmacological inhibition of the electron transport chain disproportionately impair the immediate cytotoxic capacity of IELs compared to other lymphocyte populations when challenged with a stimulus? 2. **Hypothesis:** IELs orchestrate a multi-layered mucosal defense program by coupling direct cytotoxicity with alarmin signaling. Upon detecting stressed epithelial cells, they first engage a direct killing mechanism via molecules like [GZMA](/details-gene/3001). Concurrently, or as a result of this interaction, they actively release DAMPs such as [HMGB1](/details-gene/3146) to act as a secondary "call for help," recruiting and activating myeloid cells to manage the resulting cellular debris and coordinate a broader inflammatory response. * **Surprising Findings:** The high specificity of a ubiquitously expressed nuclear protein like [HMGB1](/details-gene/3146) for IELs suggests it plays a specialized, cell-type-specific role beyond its general function, possibly involving a regulated secretion pathway that is a core part of their immunological function. * **Testable Questions:** Using an *in vitro* co-culture system of IELs and epithelial cells, can we detect the active, non-lytic secretion of [HMGB1](/details-gene/3146) from IELs following stimulation through their activating receptors? Furthermore, does the supernatant from these activated IEL cultures induce a pro-inflammatory phenotype (e.g., TNF-alpha, IL-6 production) in macrophages, and is this effect neutralized by an anti-HMGB1 antibody?